Bridging the gap

between instability and rehabilitation

Creating an ML-optimisation platform that generates patient-specific bioactive recipes for joint implants and coatings; designed for the patients current orthopaedics ignores.

1.9M

UK patients estimated with no implant designed for them

£5.6B

Global SAM — poor-candidate orthopaedic segment

50%

of hEDS patients report worsening symptoms after physiotherapy*

300M

Estimated annual NHS savings from reduced revision surgeries

*Ossava survey data

The Problem

Patients with connective tissue disorders (hEDS, HSD) and bone fragility conditions cannot safely undergo physiotherapy, yet current implants aren't built for their compromised healing biology.

The result: chronic pain, repeat urgent care, no long-term solution.

Millions stuck in the treatment gap

  • Severe joint instability prevents access to physiotherapy

  • No implant is designed for their biology

  • Compromised healing makes traditional implants inaccessible

  • ~50M patients globally stuck in limbo (modelled estimate)

Material properties

Patient biology

Rehab pathway

The Solution

Patient’s profile in. Optimal implant out.

Ossava is developing a ML engine takes each patients’ personalised biological profile and the physician-recommended rehabilitation route, paired with our proprietary database, to output a patient-specific bioactive coating formulation for joint implants.

Personalised implants Designed for each patient

Contact Us

Interested in learning more? Fill out your info and we will be in touch shortly. We can’t wait to hear from you!